ArticleInternational journal of pharmaceutics: X2026
Determination of the optimal resistance in RS01 for robust aerosol performance of inhaled controlled-release budesonide powder for chronic obstructive inflammatory respiratory diseases patients.
Le Van Bui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.